miR-27b |
hUC-MSCs |
HaCaT cells and HSFs |
Target ITCH/JUNB/IRE1α axis |
Improve proliferation and migration of HaCaT cells and HSFs |
Cheng et al. (2020)
|
miR-21-5p |
Mag-BMSCs |
HUVECs and HSFs |
Inhibit SPRY2 and activate PI3K/AKT and ERK1/2 Pathways |
Accelerate wound healing |
Wu et al. (2020c)
|
miR-135a |
Human amnion MSCs |
Human fibroblast BJ-1 cells |
Down-regulate LATS2 levels |
Promote BJ-1 cells migration |
Gao et al. (2020)
|
miR-486-5p |
ADSCs |
HSFs and HMECs |
Regulate the Sp5/CCND2 |
Promote HSF proliferation, migration, and HMEC angiogenesis |
Lu et al. (2020)
|
miR-425-5p miR-142-3p |
EPSCs |
HDFs |
Down-regulate the expression of TGF-β1 |
Inhibit myofibroblast differentiation |
Duan et al. (2020)
|
miR-126 miR-130a miR-132 miR124a miR-125b miR-21 |
Human circulating fibrocytes |
Diabetic KCs |
N/A |
Promote migration and proliferation of diabetic keratinocytes and enhance angiogenesis |
Geiger et al. (2015)
|
miR-21-3p |
hUC-blood plasma |
HSFs and HMECs |
Inhibit PTEN and SPRY1 |
Promote HSF proliferation, migration, and HMEC angiogenesis |
Hu et al. (2018)
|
miR-16-5p |
Induced pluripotent stem cells |
HaCaT cells |
Activate p38/MARK pathway by targeting Desmoglein 3 |
Promote deep second-degree burn wound healing |
Yan et al. (2020)
|
miR-21 |
HEKa |
HFF-1, endothelial cells |
Down-regulate PTEN/RECK, and activate MAPK/ERK signaling |
Promote fibroblast migration, differentiation, and contraction, enhance angiogenesis and promote the inflammatory response |
Li et al. (2019b)
|
miR-20b-5p |
Plasma of diabetic patients |
HUVECs |
Inhibit of the Wnt9b/β-catenin signaling pathway |
Inhibit angiogenesis |
Xiong et al. (2020)
|
miR-20b-5p |
Plasma of diabetic patients |
HSFs |
Suppress VEGFA expression |
Suppress HSF proliferation and promote apoptotic death. |
Chen et al. (2021)
|
miR-221-3p |
EPCs |
N/A |
Possibly target AGE-RAGE, p27, and p57 |
Promote angiogenesis and cell proliferation |
Xu et al. (2020b)
|
miR-106b |
HUVECs |
LL29 fibroblast cells and HaCaT keratinocytes |
Inhibit JMJD3 and RIPK3 |
Reduce adhesion and viability of fibroblasts and keratinocytes and inhibit collagen I content and angiogenesis |
Qi et al. (2021)
|
miR-24-3p |
Plasma of diabetic patients |
HUVECs |
Down-regulate PIK3R3 expression |
Inhibit angiogenesis, survival, and migration of HUVECs |
Xu et al. (2020c)
|
lncRNA H19 |
MSCs |
Fibroblasts |
Sponge miR-152-3p and up-regulated PTEN to inhibit PI3K/AKT signaling pathway |
Prevent the apoptosis and inflammation of fibroblasts |
Li et al. (2020)
|
lncRNA-H19 |
EMNVs |
HMEC-1 |
Impair PI3K/AKT signaling pathway |
Promote EC proliferation, migration, and angiogenesis |
Tao et al. (2018)
|
MALAT1 |
ADSCs |
HaCaT and HDF cells |
Sponge miR-124 and activate Wnt/β-catenin pathway |
Promote the proliferation and migration of HaCaT and HDF cells |
He et al. (2020)
|
has_circ_0075932 |
Adipocytes |
Dermal KCs |
Bind with PUM2 and up-regulating AuroraA/NF-kB pathway |
Promote inflammation and apoptosis in keratinocytes to impair wound healing |
Zhang et al. (2019)
|
mmu_circ_0000250 |
ADSCs |
EPCs |
Induce miR-128-3p/SIRT1-mediated autophagy |
Promote EPC proliferation and angiogenesis to accelerate diabetic wound healing |
Shi et al. (2020b)
|